Opinion: I tried to design a clinical trial for a supplement. 5 things got in the way
Designing a publication-quality randomized trial for a botanical supplement faces five structural barriers. These include weak patent incentives, high trial costs and underpowered samples, decentralized trial complexities, and FDA limits on clinical claims.
Why it mattersFDA scrutiny of clinical endpoints pushes supplement trials to wellness outcomes, raising sample sizes and costs for sponsors.
Entities Mentioned
FDA
People Mentioned
Elise Felicione